The safety of our patients is a priority at AstraZeneca, so we consider it important to inform and document the benefits and risks of our treatments and keep safety profiles up to date. WHO defines Pharmacovigilance as the science and activities relating to the detection, evaluation, understanding and prevention of adverse effects of medicines or any other related health problems.
Our team collects, and evaluates information about drug side effects in order to identify relevant information and thus prevent future risks to our patients. When a possible safety event is identified, health authorities are informed and the local prescribing information is updated if necessary.
Reporting adverse events is of vital importance as this information allows to know the safety profile of our medications under actual prescription condition. In addition, as part of our commitment to providing safe medicines to our patients, we have a department dedicated to addressing any questions that directly impact the quality of our treatments in order to proactively avoid defects and products that do not conform to local standards and global.